About this episode
In 1983, Congress passed the Orphan Drug Act which incentivized the development of treatments for rare diseases. Since passing, the legislation has helped to create hundreds of new treatments for rare diseases... but it may have also had some side effects. According to Dr. Peter Bach, a pulmonologist and intensive care physician at Memorial Sloan Kettering Cancer Center, the push towards finding cures for rare diseases has been so strong that drug companies are paying little attention to more common illnesses, including some of the leading causes of death in the United States, like heart disease, cancer, and diabetes.
Get every episode summarized
Each time Innovation Hub publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
